Avantex Biotechnologies Inc.
  • About
    • Overview
    • Management & Directors
    • Disclaimer
  • Applications
    • Lung Cancer Application
      • – Lung Cancer Problem
      • – Lung Cancer in China
    • Eye-Care Application
    • MRI Application
    • Cannabis Applications
    • Published Research Papers
  • News
    • Industry News
    • Media Contact
  • Contact
    • Contact Information
  • Search
  • Menu Menu

About Avantex

Disclaimer, Trade Mark and Privacy Statement

Disclaimer
While Avantex Biotechnologies Inc. (“Avantex”) has taken all reasonable care to ensure the accuracy of the information on this website, we shall not be held responsible for any eventualities arising from the use of this information. Visitors to this web site are advised to seek independent financial advice prior to making investment decisions. The information on this website may be downloaded for personal use, but may not be reproduced or modified without the permission of Avantex.

In using this website, you may be linked to web sites provided by independent third parties. If you click-through to any such third party sites, either directly or indirectly through this site, you acknowledge and agree that you shall be subject to the terms and conditions of usage applicable to such third party sites. Any and all content to which you link, either directly or indirectly, from this site will not have been developed, reviewed or monitored by Avantex and Avantex cannot and does not guarantee or make any representation or warranty, either express or implied, as to the accuracy, validity, sequence, timeliness, completeness or continued availability of any such content. Avantex does not endorse or accept liability for the content of such third party sites nor does it claim any trade association with the proprietors of such third party sites.

Copyright and Trade Mark Notice
Avantex owns a copyright in the selection and arrangement of the content of this website, as well as in the content original to it. No unauthorized copying of any part of this website is permitted. However, Avantex authorizes you to make print copies of, or download documents or pages published by Avantex on this website for your own personal, non-commercial use only, provided that any copy of these documents that you make retains all copyright and other proprietary notices, and any disclaimer contained thereon. You may not offer for sale or distribute over any medium, any part of this website or any of its content.

Trademark law protects elements of this site. Except for the limited permission authorizing you to print copies of or download material on this site, nothing on this website should be construed as granting any other right or license under any copyright or trademark of Avantex or any third party.

Privacy Statement
Avantex operates this web site. Avantex is concerned for and respects the privacy of each visitor to this web site. When you visit certain areas of this web site you may be asked for personal information such as your name, address, telephone number and e-mail address. The intended use of such information is specified at the site where the information is collected. No personal information about you shall be collected without your consent.

Avantex also collects aggregated or non-personal information to track data such as the total number of visits to this web site or the number of visitors to each web page. This information shall remain in aggregated form and may be used to understand how visitors use this web site.

Avantex will take reasonable precautions to prevent the loss, misuse or alteration of the information you provide. Any contractors, agents or representatives of Avantex who are required to have access to this information in the course of providing services to Avantex are required to keep that information confidential.

  • Overview
  • Management & Directors
  • Disclaimer

INDUSTRY NEWS

  • Graphite Nanomaterials Reviewed for Role in Drug Delivery SystemsAugust 18, 2022 - 9:33 pm
  • Samsung invests $15 million in US biotech firm to develop core nanotechnology drug deliveryAugust 12, 2022 - 10:03 pm
  • Mesoporous silica nanoparticles: Possibilities in therapeutic developmentJuly 28, 2022 - 10:00 pm
  • How different cancer cells respond to drug-delivering nanoparticlesJuly 22, 2022 - 9:19 pm
  • What to Expect From the Launch of Cannabis Edibles in CanadaDecember 31, 2019 - 12:00 pm
  • New Cannabis Products to Follow Edibles LegalizationSeptember 5, 2019 - 12:00 pm

ABOUT
Overview
Management & Directors
Disclaimer

BIOTECH APPLICATIONS
Eye-Care Application
Lung Cancer Application
– Lung Cancer Problem
– Lung Cancer in China
Cannabis Applications
MRI Application
Research Papers

NEWS
Industry News
Media Contact

CONTACT
Contact Information

CONTACT
Nikita Chou, President
E: nchou@avantexbio.com
M: +1-778-888-3892

Ullrich Schade, VP Marketing
E: uschade@avantexbio.com
M: +1-604-644-4914

Branding by:
NextPhase Strategy

Scroll to top